NovaBridge Biosciences (NBP) Intangibles (2018 - 2023)

NovaBridge Biosciences (NBP) has 6 years of Intangibles data on file, last reported at $16.4 million in Q4 2023.

• Quarterly Intangibles fell 1.87% year-over-year to $16.4 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.4 million (down 1.87% YoY) and the FY2023 annual result came in at $16.7 million, down 99.9% from the prior year.
• Intangibles steadied at $16.4 million in Q4 2023 per NBP's latest filing, from $16.3 million in the prior quarter.
• Across five years, Intangibles topped out at $18.7 billion in Q4 2021 and bottomed at $16.3 million in Q2 2023.
• The 5-year median for Intangibles is $18.1 million (2020), against an average of $1.9 billion.
• The widest annual swing landed in 2021, when Intangibles jumped 102886.2%; it then sank 99.91% in 2022.
• Tracing NBP's Intangibles over 5 years: stood at $21.1 million in 2019, then declined by 13.94% to $18.2 million in 2020, then jumped by 102886.2% to $18.7 billion in 2021, then slumped by 99.91% to $16.7 million in 2022, then fell by 1.87% to $16.4 million in 2023.
• Per Business Quant, the three latest NBP Intangibles figures stand at $16.4 million (Q4 2023), $16.3 million (Q2 2023), and $16.7 million (Q4 2022).

Peer Comparison